Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Neuropsychology. 2012 Jan 16;26(2):156–164. doi: 10.1037/a0026799

Table 1.

Details on three cohorts included in the collaboration.

Cohort Citation Recruitment Inclusion Exclusion
1 Cornish et al. 2008 United Kingdom
Clinical Genetics
Services and Fragile
X Society
Age 18-50
English-
speaking
IQ less than 85, stroke, dementia
2 Hunter et al. 2008 FXS conferences and
support groups, word
of mouth, sports
events, health fairs,
churches
Age 18-50
English-
speaking
Active substance abuse/addiction, head
trauma with loss of consciousness,
meningitis, oxygen deprivation, Multiple
Sclerosis, Amyotrophic Lateral Sclerosis,
Parkinson’s disease, severe chronic fatigue
syndrome, complicated migraines
(temporary stroke-like effects) with
progressive memory impairment, stroke or
brain hemorrhage, brain surgery, seizure
disorder, schizophrenia, active use of
sedating medications
3 Grigsby et al. 2008, Brega et al. 2008 FXS study subjects at
University of
Colorado Denver and
University of
California Davis,
FXS support groups,
employees at CU
Denver and Health
Sciences Center
Over age 40
English-
speaking
Significant speech/language deficits that
make participation impossible, head trauma
with loss of consciousness, epilepsy,
demyelinating disease, family history of non-
FXS genetic neurologic disorder, other
neurologic disorders (e.g., stroke), complex
medical comorbidities that may affect
cognition, contraindications for MRI
scanning (e.g., pacemaker, metal in body),
schizophrenia, manic episodes, psychotic
depression, alcoholism or significant drug
use, medications affecting cognition

FXS=Fragile X Syndrome